Biogen
In Joel Greenblatt's portfolio · Gotham Asset Management
Ticker BIIB
Not in the portfolio as of Q2 2026. Every quarter it shows up in a Gotham Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2020 | Reduce 25% | 99,882 | 0.8% |
| Q1 2020 | Reduce 16% | 133,975 | 1.2% |
| Q4 2019 | Reduce 9% | 159,766 | 0.9% |
| Q3 2019 | Add 13% | 175,027 | 0.7% |
| Q2 2019 | Add 3% | 155,286 | 0.6% |
| Q1 2019 | Add 42% | 151,252 | 0.5% |
| Q4 2018 | Add 34% | 106,435 | 0.5% |
| Q2 2017 | Reduce 41% | 162,464 | 0.6% |
| Q1 2017 | Add 15% | 275,460 | 1.0% |
| Q4 2016 | Reduce 2% | 240,311 | 0.9% |
| Q3 2016 | Reduce 33% | 245,468 | 1.0% |
| Q2 2016 | Add 23% | 368,095 | 1.1% |
| Q1 2016 | Add 253% | 298,673 | 0.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.